Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma, Skin cancer
Closed
Phase 2
This trial is looking at a drug called PLX3397 for melanoma that has spread into the surrounding tissues or to another part of the body (advanced melanoma). It is for people who have:
2 unusual types of melanoma called and
A gene change () in the melanoma cells called KIT
This trial is supported by Cancer Research UK.
Recruitment start: 28 October 2015
Recruitment end: 28 March 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Lorigan
Cancer Research UK
Christie Charitable Funds ‘’Elis for life’’
Central Manchester for Genomic Medicine
Experimental Cancer Medicine Centre (ECMC)
Oxford University Hospitals NHS Trust
The Christie NHS Foundation Trust
The Institute of Cancer Research
University of Manchester
This is Cancer Research UK trial number CRUK/12/020
Last reviewed: 27 May 2019
CRUK internal database number: 9540
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
